Onderneming Bellevue Life Sciences Acquisition Corp.
Aandelen
BLAC
US0791741087
Holdingvennootschappen
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
10,8 USD | +0,37% | 0,00% | +2,86% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Guk-Hyun Hwang
CEO | Chief Executive Officer | 48 | 01-03-20 |
Jin Yoo
DFI | Director of Finance/CFO | 50 | 01-09-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Reed
CHM | Chairman | 73 | 14-02-23 |
In-Chul Chung
BRD | Director/Board Member | 60 | 14-02-23 |
Guk-Hyun Hwang
CEO | Chief Executive Officer | 48 | 01-03-20 |
Jun Chul Whang
BRD | Director/Board Member | 59 | 01-08-20 |
Rad Roberts
BRD | Director/Board Member | 56 | 14-02-23 |
Jin Park
BRD | Director/Board Member | 56 | 14-02-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 4 041 221 | 1 940 721 ( 48,02 %) | 0 | 48,02 % |
Bedrijfsgegevens
Bellevue Life Sciences Acquisition Corp.
10900 NE 4th Street Suite 2300
98004, Bellevue
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,86% | 60,73 mln. | |
+190,94% | 7,13 mld. | |
+2,14% | 982 mln. | |
+41,91% | 872 mln. | |
+26,98% | 820 mln. | |
+1,72% | 664 mln. | |
+5,92% | 648 mln. | |
-.--% | 600 mln. | |
+3,61% | 503 mln. | |
-.--% | 500 mln. |
- Beurs
- Aandelen
- Koers BLAC
- Onderneming Bellevue Life Sciences Acquisition Corp.